{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+study&page=57", "query": { "intervention": "Cohort study", "page": 57 }, "page_size": 10 }, "pagination": { "page": 57, "page_size": 10, "total_count": 11177, "total_pages": 1118, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+study&page=58&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Cohort+study&page=56&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T14:18:13.961Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01428297", "title": "A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Atopic Dermatitis", "Netherton Syndrome" ], "interventions": [ { "name": "BPR277 ointment (controlled application)", "type": "DRUG" }, { "name": "Placebo (Vehicle)", "type": "DRUG" }, { "name": "BPR277 ointment", "type": "DRUG" }, { "name": "BPR277", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 12, "start_date": "2011-05", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 3, "location_summary": "New Haven, Connecticut • St Louis, Missouri • Fargo, North Dakota", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01428297" }, { "nct_id": "NCT03705169", "title": "Pharmacokinetics and Safety of SAR441236", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV-1-infection" ], "interventions": [ { "name": "SAR441236", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 52, "start_date": "2019-05-20", "completion_date": "2022-04-04", "has_results": true, "last_update_posted_date": "2024-01-12", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03705169" }, { "nct_id": "NCT02659020", "title": "A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Soft Tissue Sarcoma" ], "interventions": [ { "name": "Olaratumab", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 310, "start_date": "2016-03-01", "completion_date": "2021-04-27", "has_results": true, "last_update_posted_date": "2022-05-09", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 21, "location_summary": "Santa Monica, California • Aurora, Colorado • Jacksonville, Florida + 17 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02659020" }, { "nct_id": "NCT00753220", "title": "Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "VDC2008", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Bostwick Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 7, "start_date": "2009-08", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2014-11-04", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00753220" }, { "nct_id": "NCT05926024", "title": "Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Exercise Recall Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Functional Assessment of Cancer-Gynecology Oncology Group-Neurotoxicity (FACT/GOG-NTX-12)", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PROMIS", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes FACT-Endocrine Symptoms", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes Penn Arthralgia Aging Survey", "type": "BEHAVIORAL" }, { "name": "Patient Reported Outcomes PRO-CTCAE (patient-reported CTCAE)", "type": "BEHAVIORAL" }, { "name": "p16 tumor suppressor gene", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "BEHAVIORAL", "DIAGNOSTIC_TEST" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 253, "start_date": "2023-01-06", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05926024" }, { "nct_id": "NCT05789524", "title": "The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hemophilia a", "Hemophilia B" ], "interventions": [ { "name": "SerpinPC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ApcinteX Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "MALE", "summary": "12 Years to 65 Years · Male only" }, "enrollment_count": 60, "start_date": "2023-07-06", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 10, "location_summary": "Aurora, Colorado • Tampa, Florida • Indianapolis, Indiana + 7 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05789524" }, { "nct_id": "NCT04478279", "title": "A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glioblastoma", "Melanoma Stage IV", "Breast Cancer", "Prostate Cancer", "Glioblastoma Multiforme", "GBM", "Brain Cancer", "Metastatic Breast Cancer", "Metastatic Melanoma", "Metastatic Prostate Cancer", "Melanoma Recurrent", "Prostate Cancer Metastatic", "Recurrent Glioblastoma", "Newly Diagnosed Glioblastoma" ], "interventions": [ { "name": "ST101", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Sapience Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2020-07-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-02-09", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 7, "location_summary": "San Francisco, California • Denver, Colorado • Warrenville, Illinois + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Warrenville", "state": "Illinois" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04478279" }, { "nct_id": "NCT05589896", "title": "A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Acute Biphenotypic Leukemia", "Acute Undifferentiated Leukemia", "CLL (Chronic Lymphocytic Leukemia)", "Chronic Myeloid Leukemia (CML)", "MDS (Myelodysplastic Syndrome)", "Non-Hodgkin Lymphomas", "Hodgkins Lymphoma", "Cutaneous T Cell Lymphomas (CTCL)" ], "interventions": [ { "name": "Ossium HPC Marrow, Bone Marrow Transplant", "type": "OTHER" }, { "name": "Pre-transplant conditioning - Myeloablative (MAC)", "type": "OTHER" }, { "name": "Pre-transplant conditioning - Reduced Intensity (RIC)", "type": "OTHER" }, { "name": "Post-transplant treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ossium Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 12, "start_date": "2024-08-16", "completion_date": "2029-05-31", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 9, "location_summary": "Duarte, California • Tampa, Florida • Atlanta, Georgia + 6 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05589896" }, { "nct_id": "NCT02605083", "title": "A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "eFT508", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Effector Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2015-12-03", "completion_date": "2019-03-22", "has_results": false, "last_update_posted_date": "2020-11-02", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 4, "location_summary": "Denver, Colorado • Sarasota, Florida • Nashville, Tennessee + 1 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02605083" }, { "nct_id": "NCT00874380", "title": "Fiber Intake in an End Stage Renal Disease (ESRD) Population Followed Over 2 Years", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Outcome", "Kalemia Control", "Lipid Profile" ], "interventions": [ { "name": "Increasing total fiber intake in patient's diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 70, "start_date": "2008-10", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2013-05-15", "last_synced_at": "2026-11-07T14:18:13.961Z", "location_count": 1, "location_summary": "Staten Island, New York", "locations": [ { "city": "Staten Island", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00874380" } ] }